Estrogen hormone 17b-estradiol (E 2 ) is involved in the physiology and pathology of many tissues. E 2 information is conveyed by the transcription factors estrogen receptors (ER) a and b that mediate a complex array of nuclear and non-nuclear events. The interaction of ER with specific DNA sequences, estrogen-responsive elements (EREs), constitutes a critical nuclear signaling pathway. In addition, E 2 -ER regulates transcription through interactions with transfactors bound to their cognate regulatory elements on DNA, hence the ERE-independent signaling pathway. However, the relative importance of the EREindependent pathway in E 2 -ERb signaling is unclear. To address this issue, we engineered an ERE-binding defective ERb mutant (ERb EBD ) by changing critical residues in the DNA-binding domain required for ERE binding. Biochemical and functional studies revealed that ERb EBD signaled exclusively through the ERE-independent pathway. Using the adenovirus infected ER-negative cancer cell models, we found that although E 2 -ERb EBD regulated the expression of a number of genes identified by microarrays, it was ineffective in altering cellular proliferation, motility, and death in contrast to E 2 -ERb. Our results indicate that genomic responses from the ERE-independent pathway to E 2 -ERb are not sufficient to alter the cellular phenotype. These findings suggest that the ERE-dependent pathway is a required signaling route for E 2 -ERb to induce cellular responses.
Introduction
Estrogen hormones, particularly the main circulating estrogen, 17b-estradiol (E 2 ), play important roles in the regulation of many tissue functions (Huang et al. 2005a , Deroo & Korach 2006 ). E 2 is also involved in the initiation and development of target tissue malignancies. The E 2 information is primarily conveyed by estrogen receptors (ER) a and b (Huang et al. 2005a , Deroo & Korach 2006 . ERs are members of the conserved superfamily of hormone receptors and are ligand-activated transcription factors. The effects of E 2 -ER are exerted through a complex array of convergent and divergent signaling pathways that mediate genomic events involved in the regulation of mitogenesis, motogenesis, and apoptosis (Hall et al. 2001 , Nilsson et al. 2001 , Huang et al. 2005a . The interaction of E 2 -ER with specific DNA sequences, estrogen-responsive elements (EREs), constitutes a primary genomic signaling pathway (Hall et al. 2001 , Nilsson et al. 2001 , Huang et al. 2005a . The ERE-bound ER recruits an ensemble of multi-subunit complexes responsible for the alteration of local chromatin structure and the interaction with the basal transcription machinery. The integrated effects of these complexes regulate transcription. This type of E 2 -ER-mediated signaling is referred to as the ERE-dependent signaling pathway (Hall et al. 2001 , Nilsson et al. 2001 , Huang et al. 2005a .
In addition, the E 2 -ER complex regulates the expression of E 2 -responsive genes through functional interactions with transcription factors bound to their cognate regulatory elements on DNA (Kushner et al. 2000 , Safe 2001 ). In this DNA-dependent and ERE-independent signaling pathway, transcriptional responses are dependent upon the ER-subtype, promoter, and cellcontext (Kushner et al. 2000 , Safe 2001 ). However, the relative importance of the ERE-independent pathway in physiology and pathophysiology of E 2 -ERb signaling is unknown. We envisioned that a selective regulation of the ERE-independent genes would allow us to begin to address this issue. To accomplish this, we generated an ERE-binding defective ERb mutant (ERb EBD ) which renders the receptor nonfunctional at the ERE-dependent pathway, while conserving the regulatory potential at the ERE-independent pathway. We used ER-negative cells as experimental models, with which exogenously introduced ERs were shown to regulate the expression of responsive genes (Licznar et al. 2003 , Kian Tee et al. 2004 , Stossi et al. 2004 , Moggs et al. 2005 , Monroe et al. 2005 and to induce phenotypic changes (Garcia et al. 1992 , Jiang & Jordan 1992 , Zajchowski et al. 1993 , Lazennec & Katzenellenbogen 1999 , Lazennec et al. 2001 , Licznar et al. 2003 . In adenovirus-infected cells, we found that genomic responses induced by ERb EBD in response to a physiological level of E 2 are insufficient to alter cellular proliferation, death, or motility, in contrast to E 2 -ERb. These results imply that the ERE-dependent pathway is the required signaling route mediated by the E 2 -ERb complex.
Materials and methods

Generation of ERb DNA-binding defective mutant (ERb EBD )
The human ERb cDNAs that encode the 530 amino acid ERb have been described previously (Yi et al. 2002a) . This ERb cDNA also contains sequences encoding an amino-terminal Flag epitope (Yi et al. 2002a) . For the engineering of an ERE-binding defective ERb (ERb EBD ), we utilized an overlapping PCR with the ERb cDNA as the template and primers that contain amino acid substitutions to replace glutamic acid and glycine at positions 167 and 168 respectively with alanine residues in the first zinc finger of the DNA-binding domain (DBD) of the receptor.
Restriction and DNA modifying enzymes were obtained from New England Bio-Labs (Beverly, MA, USA) and Invitrogen.
Cell culture
The culturing of MDA-MB-231 and HeLa cells has been described previously (Yi et al. 2002a) . U-2 OS cells derived from osteosarcoma were purchased from ATCC (Manassas, VA, USA). U-2 OS cells were grown in McCoy's 5a medium supplemented with 10% fetal bovine serum (FBS, Invitrogen) . In all experiments, the medium was changed every third day.
Transient transfections
Transient transfections for the simulated ERE-dependent and -independent pathways were accomplished as described previously (Yi et al. 2002a . The transfected cells were treated without or with 10 K9 M of E 2 , 10 K7 M of 4-hydroxyl-tamoxifen (4-OHT, Sigma-Aldrich), 10 K7 M ICI 182 780 (Imperial Chemical Industries, Tocris Inc., Ballwin, MO, USA), and 10 K8 M diarylpropionitrile (DPN, Tocris) for 24 or 40 h to assess the effects of ligands on ER-mediated transcriptional responses from the ERE-dependent or -independent signaling pathways respectively.
Generation of a recombinant adenovirus bearing an ER cDNA
Recombinant adenovirus bearing none, the cDNA of Flag-ERb or Flag-ERb EBD were produced using the AdEasy-XL Adenoviral System (Stratagene, La Jolla, CA, USA) as described previously (Huang et al. 2005b) . The purified viruses were titered using an Adeno-X Rapid Titer Kit (BD Biosciences, Palo Alto, CA, USA) to determine the multiplicity of infection (MOI).
Western blot (WB), electrophoretic mobility shift assay (EMSA), and immunocytochemistry (ICC) Transfected or infected cells in a time-dependent manner were processed for WB, EMSA, and ICC as described previously (Muyan et al. 2001 , Yi et al. 2002a . For WB, proteins were probed with horseradish peroxidaseconjugated monoclonal Flag antibody (M2-HRP, Sigma-Aldrich) using the ECL-Plus Western Blotting kit (Amersham-Pharmacia). The images were captured using PhosphorImager (Molecular Dynamics, Sunnyvale, CA, USA). For ICC, we used an ERb-specific antibody (Zymed Laboratories, San Francisco, CA, USA) followed by a fluorescein conjugated secondary antibody (Santa Cruz Biotechology, Santa Cruz, CA, USA).
In situ E 2 binding and ERE competition assays
To assess the functionality of ERb species in transfected cells, we used the in situ E 2 binding assay and the in situ ERE competition assays as described previously (Huang et al. 2005b) .
assess the effects of ER on the expression of the trefoil factor 1 (TFF1), complement factor 3 (C3), matrix metallopeptidase 1 (MMP1), and retinoic acid receptor a (RARA) genes.
The cells were also infected with recombinant adenoviruses in the absence of E 2 and maintained for 48 h, the time during which the synthesis of ERs reaches comparable levels (Fig. 1 ). The infected cells were then treated with 10 K9 M E 2 for 6, 12, or 24 h to confirm the identities of genes determined by microarrays using quantitative PCR (qPCR). At termination, the cells were collected and subjected to total RNA extraction using the RNeasy Mini Kit (Qiagen) for qPCR, which we used custom TaqMan Low-Density Arrays with proprietary primer and probe sequences (Applied Biosystems, Foster City, CA, USA). All qPCRs were carried out at the Functional Genomic Center of the University of Rochester, NY, USA. The expression of the actin b (ACTB) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes was used as the control. The Figure 1 Generation of an ERE-binding defective ERb (ERb EBD ). (A) ERb EBD was engineered by changing glutamic acid and glycine at positions 167 and 168 of the first zinc finger of the DNA-binding domain of the ERb respectively to alanine residues. (B) The synthesis of ERb species. MDA-MB-231 cells were transiently transfected with an expression vector bearing none (V), the ERb or ERb EBD cDNA. Cell extracts (10 mg) were subjected to western blotting (WB) using a horseradish peroxidase-conjugated monoclonal Flag antibody. MW in KDa is indicated. The cell extracts (20 mg) of transfected cells were also subjected to electrophoretic mobility shift assay (EMSA) without (K) or with (C) a Flag antibody (Ab). ERE denotes unbound and ER-ERE indicates ER-bound radiolabeled ERE. Representative results from three independent experiments of WB and EMSA are shown. (C) The in situ ERE competition assay. MDA-MB-231 cells were transiently transfected with a reporter vector bearing one ERE upstream of the TATA box promoter driving the expression of Firefly luciferase cDNA and the expression plasmid for PPVV, together with various concentrations of expression vector bearing the ERb or ERb EBD cDNA. The cells were also co-transfected with a reporter plasmid bearing Renilla luciferase cDNA to monitor the transfection efficiency. The cells were then treated without (KE 2 ) or with (CE 2 ) 10 K9 M E 2 for 24 h. The relative luciferase activity was presented as the percentage (%) change compared with control (PPVV alone in the absence of E 2 ), which was set to 100%. The mean of three independent experiments performed in duplicate has been shown. S.E.M., which was less than 15% of the mean, is not shown for simplicity. (D) Chromatin immunoprecipitation (ChIP) assay. MDA-MB-231 cells were transiently transfected with an expression vector bearing the ERb or ERb EBD cDNA together with a reporter bearing none (TATA) or one ERE TATA box promoter. The cells were treated without (K) with (C) 10 K7 M E 2 for 1 h prior to ChIP using the Flag antibody-conjugated agarose beads. The size of the DNA fragment is indicated in bp. A representative image from three independent experiments is shown.
real-time RT-PCR amplifications were accomplished using an ABI Prism 7900HT Sequence Detection System with a TaqMan Low Density Array Upgrade (Applied Biosystems). Relative quantification analysis was performed using the comparative C T method (Livak & Schmittgen 2001) .
Cell proliferation
MDA-MB-231 cells (5000 cells/well) plated in 24-well tissue culture plates in phenol red-free DMEM containing 10% CD-FBS for 24 h were infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for different durations of time. The cells were collected and counted using a hemacytometer (Hausser Scientific, Horsham, PA, USA).
Additionally, we used a colorimetric proliferation assay, the 3-(4,5 dimethylthiazol-2yl)2,5-diphenyltetrazolium bromide (MTT) assay (Mosmann 1983 ). The cells, plated and infected with adenoviruses as described for hemacytometric cell counting, were incubated with 200 ml phenol red-free DMEM with 10% CD-FBS containing 60 mM MTT (Invitrogen) for 2 h. The spent medium was removed and 200 ml dimethyl sulfoxide (DMSO) was added to each well to dissolve the MTT formazan. The absorbance was measured using a microplate spectrophotometer (SpectraMax Plus; Molecular Devices, Sunnyvale, CA, USA) to estimate the cell number.
For U-2 OS cell proliferation, cells (5000 cells/well) were plated in 24-well tissue culture plates, pre-coated with poly-L-lysine (Sigma-Aldrich), in McCoy's 5a medium containing 10% FBS, for 24 h. The cells were subsequently incubated with McCoy's 5a medium containing 10% CD-FBS for an additional 24 h. They were then infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for different durations of time. We used Ad5-ERb at 40 MOI. At this concentration, the recombinant adenovirus synthesized a concentration of ERb that is dependent upon E 2 for functioning. Ad5-ERb EBD was used at 50 MOI, which produced levels of receptor comparable to that of ERb. At the termination of an experiment, cells were subjected to cell counting and MTT assays.
Cell cycle analysis
MDA-MB-231 cells (50 000 cells/well) in six-well tissue culture plates were infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for different durations. The cells were collected and pelleted. For fixing and permeabilization, the pelleted cells were resuspended in ethanol (70%) at 4 8C overnight. The cells were subsequently incubated with 1 mg/ml RNase A (Sigma-Aldrich) for 30 min followed by 20 mg/ml propidium iodide (PI) (Sigma-Aldrich) for 10 min.
They were then subjected to fluorescence-activated cell sorting (FACS) using EPICS Elite (Coulter Corp., Miami, FL, USA).
Caspase 3/7 assay MDA-MB-231 cells (12 500 cells/well) plated onto poly-Llysine coated 96-well tissue culture black plates with clear bottom (BD Biosciences, Franklin Lakes, NJ, USA) in phenol red-free DMEM containing 10% CD-FBS for 24 h were infected with recombinant adenoviruses, in the absence or presence of 10 K9 M E 2 , for different lengths of time. The cells were then subjected to Apo-ONE Homogeneous Caspase-3/7 Assay (Promega) according to the manufacturer's protocol. Fluorescence was then measured using a spectrophotometer.
Annexin V assay
To study apoptosis by examining the loss of cell membrane asymmetry as an indicator of middle stages of apoptosis, we used the Vybrant Apoptosis Assay Kit (Invitrogen). This assay is based on the specific recognition of phosphatidyl-serine (PS) by FITC-conjugated annexin V. MDA-MB-231 cells (100 000 cells/ well) were infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for different lengths of time. The cells were collected and subjected to annexin V assay, according to the instruction of the manufacturer, prior to FACS analysis.
TUNEL assay
To study the late stages of apoptosis by examining the fragmentation of genomic DNA (Korsmeyer 1999) , MDA-MB-231 cells (25 000 cells/well) plated in poly-L-lysinecoated 48-well tissue culture plates in phenol red-free DMEM containing 10% CD-FBS for 24 h and infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for different lengths of time. The cells were then subjected to a TUNEL assay using the DeadEnd Flurometric TUNEL System (Promega), according to the manufacturer's protocol. 4 0 ,6-diamino-2-phenylindole (DAPI) (Vector Labs, Burlingame, CA, USA) was used to stain cell nuclei. The stained cells were imaged under a microscope with corresponding filters.
Wound-healing assay
MDA-MB-231 cells (200 000 cells/well in 12-well tissue culture plates) were infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for 48 h for confluence. A wound was then created using a 1 ml pipette tip. The gap closure was photographed every 24 h. Due to the irregular shape of the edges of a wound, five randomly selected cross edges were used to obtain a mean gap measure for wound healing.
Invasion assay
We used BD Matrigel Invasion Chambers (BD Biosciences, San Diego, CA, USA) for the invasion assay. MDA-MB-231 cells (100 000 cells/well) in six-well tissue culture plates were infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for 48 h. The cells were then trypsinized and counted. The same number (25 000 cells/chamber) of cells was seeded on the upper section of the chamber, which contained phenol red-free DMEM without or with 10 K9 M E 2 . The lower section of the chamber contained phenol red-free DMEM supplemented with 10% CD-FBS and 30 mg/ml fibronectin in the absence or presence of 10 K9 M E 2 . After 24 h incubation, the cells on the upper section of the membrane were removed using a cotton swab. The cells on the bottom of the chamber membrane were stained with the Diff-Quik Stain Set (Dade Behring, Newark, DE, USA), dried, and mounted onto a glass slide. The images were captured and the stained cells were counted from images.
Microarray analysis
To examine the effects of E 2 on endogenous gene expression mediated by ERs, MDA-MB-231 cells were infected with recombinant adenoviruses in the absence of E 2 for 48 h. The infected cells were then treated with 10 K9 M E 2 for 6 h. This duration of E 2 treatment was expected to induce significant changes in the level of immediate/early gene expression, as observed with the responses to E 2 in ERa synthesizing breast cancer cell lines (Frasor et al. 2003) . At termination, the cells were subjected to RNeasy Mini kit (Qiagen) for total RNA extraction. The processing of RNA for microarray analysis was carried out at the Functional Genomic Center of the University of Rochester, NY. cDNA synthesis and subsequent fragmentation and biotinylation of cDNA fragments were carried out using the Ovation kit (NuGEN, San Carlos, CA, USA) according to the manufacturer's procedure. The biotinylated cDNA fragments were then used for hybridization with microarrays. We used Affymetrix HG-U133 Plus 2.0 arrays (Affymetrix, Santa Clara, CA, USA). The arrays were scanned using the GeneChip Scanner 3000 7G. GeneChip Operating Software (GCOS, Affymetrix) was used for initial processing of the scanner data, including the generation of cel files. Array normalization for the Affymetrix signal method (GCOS) involves multiplying raw signals by a scaling factor such that the trimmed mean (excluding highest and lowest 2%) of all expression scores is 500 arbitrary units for every array.
Experimental sets for microarrays were replicated six independent times, executed on different days. Although we also conducted microarray data analysis based on probe sets that relied on earlier genome and transcriptome annotation (Gautier et al. 2004 , Dai et al. 2005 , Harbig et al. 2005 ) and posted at http://dbb. urmc.rochester.edu/labs/muyan/ArrayAddendum. htm, we present here the data analysis using reorganized and updated probe sets (Gautier et al. 2004 , Dai et al. 2005 , Harbig et al. 2005 ) based on the up-to-date genome, cDNA/EST clustering, and single nucleotide polymorphism information through web-based custom GeneChip library files (Chip Definition Files or CDFs, http://arrayanalysis.mbni.med.umich.edu) which increase accuracy and reduce false discovery rates (Dai et al. 2007) . Following UniGene transformation, the data sets were subjected to the N-statistic test (Klebanov et al. 2006) in conjunction with the stepdown Westfall & Young (1993) procedure controlling the familywise error rate (FWER) at a level of 0 . 05, which was reported here. Minimum Information About a Microarray Experiment (MIAME)-compliant microarray data for the six independent replicate studies have been submitted to the Gene Expression Omnibus (GEO) database (GEO 2004) with the accession number GSE9761.
Statistical analysis
Results were presented as the meanGS.E.M. of, at least, three independent experiments. Student's t-test was employed for the comparison of means between two groups wherein P!0 . 05 was considered significant.
Results
The functional characterization of the ERE-binding defective ERb (ERb EBD )
ERs recognize an ERE as a dimer mediated by a dimerization interface located in the ligand-binding domain and a weak interaction surface in the DBD (Parker 1998) . The DBD of ERa contains two zinc fingerlike modules that fold to form a single functional domain. Each DBD of the ERa dimer makes analogous contacts with one of the inverted motifs of ERE, which results in a rotationally symmetrical structure (Luisi et al. 1994) . Distinct residues in a region of the first zinc finger module of DBD, the P-box, particularly glutamic acid and glycine at positions 203 and 204 respectively, determine the DNAbinding specificity critical for sequence discrimination (Green et al. 1988) . The residues in the second zinc fingerlike module, the D-box, are involved in the discrimination of half-site spacing through a protein-protein interaction between two ER monomers (Green et al. 1988) . The human ERa and ERb share a 97% amino acid identity in their DBDs with identical residues at the P-and D-boxes (Mosselman et al. 1996) . This structural homology is reflected in the abilities of ERs to bind various ERE sequences with a similar specificity and affinity by interacting with the same nucleotides (Yi et al. 2002b) .
Studies showed that the regulation of E 2 responsive genes through ERE-independent signaling involves a functional interaction between ERs and a transcription factor bound to its cognate response element on DNA through regions which also encompass the DBD of ERs (Kushner et al. 2000 , Safe 2001 . Changing the glutamic acid and glycine at positions 207 and 208 of the mouse ERa, and at positions 167 and 168 of human ERb respectively, at the P-box of the first zinc finger of the DBD hinders the ER-ERE interactions, while conserving the capacity to regulate transcription from the ERE-independent signaling pathway ( Jakacka et al. 2001 , Bjornstrom & Sjoberg 2002 . Based on these observations, we engineered an ERE-binding defective ERb variant (ERb EBD ) bearing alanine residues at positions 167 and 168 to exclusively regulate the DNA-dependent and EREindependent pathway (Fig. 1A) .
The initial biochemical characterization of ERb EBD was carried out in transiently transfected ER-negative cell models. Cell extracts, shown for MDA-MB-231 cells, were subjected to WB and EMSA. The detection of receptor proteins by WB using a Flag antibody (M2) directed to the Flag epitope at the amino terminal of the receptors indicated that the receptors were synthesized at similar levels ( Fig. 1B, WB) . EMSA, using a 32 P-end labeled DNA fragment bearing the consensus ERE, revealed that despite the comparable level of synthesis, ERb, but not ERb EBD , interacted in vitro with ERE (Fig. 1B, EMSA) .
To ensure that ERb EBD is indeed defective in binding to ERE in situ, we used in situ ERE competition and ChIP assays. The in situ ERE competition assay is based on the ability of ER to compete for ERE binding with a designer activator, designated as PPVV, which potently and constitutively induces transcription from an ERE-driven reporter construct (Huang et al. 2005b) . The interference of the activator-mediated transcription by unliganded or liganded ERs is then taken as an indication of ER-ERE interaction. The reporter TATA box plasmid bearing none (TATA) or one ERE was co-transfected with an expression vector encoding the PPVV cDNA into cell models, shown for MDA-MB-231 cells, in the absence or presence of varying amounts of an expression vector bearing an ER cDNA without or with a physiological concentration (10 K9 M) of E 2 for 24 h. The normalized luciferase activity mediated by PPVV alone in the absence of E 2 was set to 100%. Alterations in the reporter enzyme activity as a result of a co-transfected ER cDNA without or with E 2 are depicted as percentage (%) change compared with the activity induced by PPVV alone. Previously, we (Huang et al. 2005b ) and others (Hall & McDonnell 1999) showed that ERb, in contrast to ERa, interacts with ERE in situ independent of E 2 . Consistent with this finding, our results here also reveal that transfection with increasing concentrations of the expression vector bearing ERb, but not ERb EBD , cDNA gradually decreased the luciferase activity induced by PPVV independent of E 2 (Fig. 1C) , without altering responses from the reporter plasmid bearing the TATA box promoter (data not shown).
A ChIP assay was also employed to corroborate our finding (Fig. 1D) . The expression vectors were co-transfected with the reporter TATA box promoter vector bearing none (TATA) or one ERE into MDA-MB-231 cells. The cells were treated without or with a saturating concentration (10 K7 M) of E 2 for 1 h, and processed for ChIP. We found that ERb, but not ERb EBD or the parent vector (data not shown), produced a PCR product from cells co-transfected with the reporter vector bearing ERE irrespective of whether the cells were treated with E 2 as observed with the in situ ERE competition assay (Fig. 1C) . Thus, these results collectively suggest that ERb EBD does not interact with ERE in situ as well.
To ensure that ERb EBD is functional only in the EREindependent pathway, the expression vectors were transiently transfected into ER-negative MDA-MB-231, HeLa, or U-2 OS cells. The cells were also co-transfected with a reporter vector containing a promoter driving the expression of the firefly luciferase cDNA as the reporter enzyme. Promoters were derived from the estrogen-responsive TFF1, pS2 and C3 genes that contain ERE sequences, thereby modeling the EREdependent signaling pathway (Yi et al. 2002a . The normalized activity from each reporter construct was compared with the parent expression vector (V) in the absence of E 2 , with the latter value set to 1. Results showed that the ERb EBD had no effect on luciferase activity in the absence or presence of 10 K9 M E 2 from either the TFF1 or the C3 gene promoter in all cell lines tested, shown MDA-MB-231 and HeLa cells ( Fig. 2A) . In contrast, ERb increased the reporter enzyme activity in response to E 2 from both the promoters in all cell lines.
To confirm that the transregulatory function of ERb EBD is restricted to the ERE-independent signaling pathway, we used a reporter construct that bears the proximal MMP1 or RARA gene promoter . The functional interaction of ERs with the Jun/ Fos family of proteins bound to an activator protein-1 (AP1) element in the proximal promoter of the MMP1 gene provides the basis for the responsiveness to ERs in a ligand-and cell-type dependent manner in experimental systems (Webb et al. 1995 , Paech et al. 1997 , Webb et al. 1999 , Kushner et al. 2000 . Similarly, the interaction of ER with specificity protein-1 (SP1) bound to GC boxes of the proximal promoter is critical for the X LI and others . Dissection of nuclear E 2 -ERb signaling ligand-mediated regulation of the RARA gene (Rishi et al. 1995 , Sun et al. 1998 , Safe 2001 . Transiently transfected MDA-MB-231, HeLa or U-2 OS cells were incubated without or with 10 K9 M E 2 , 10 K8 M of 2,3-bis(4-hydroxyphenyl)propionitrile (DPN), 10 K7 M of 4-hydroxytamoxifen (4-OHT), and 10 -7 M ICI 182 780 (Imperial Chemical Industries). DPN is an ERb-potency selective estrogenic compound (Harrington et al. 2003) . Results revealed that while the parent vector had no effect on transcription in the absence or presence of ligands in all cell lines tested, ERb and ERb EBD mediated the effects of ligands on the reporter enzyme activity similarly independent of promoter and cell type (Fig. 2B) . In MDA-MB-231 cells, only DNP and 4-OHT enhanced both ERb-and ERb EBD -induced responses from the RARA promoter construct, while E 2 or ICI had no effect on the reporter enzyme activity mediated by either ER. In contrast to MDA-MB-231 cells, ERs expressed in HeLa cells enhanced the reporter enzyme activity from the MMP1 promoter in response to only 4-OHT. In these cell lines, ERb or ERb EBD had no effect on the transcriptional responses from the RARA gene promoter in the absence or presence of ligands. In U2-OS cells, on the other hand, E 2 and DPN repressed the reporter enzyme activity mediated by ERb and ERb EBD from both the MMP1 and the RARA promoter constructs, whereas 4-OHT and ICI augmented responses to both the receptors.
While the transcriptional responses mediated by ER species varied depending upon the nature of ligand, promoter, and cell context, our findings clearly indicate that ERb EBD mirrored the effect of ERb on the reporter enzyme activity from reporter constructs emulating the ERE-independent signaling pathway. Our results suggest that ERb EBD retains its transregulatory function in the ERE-independent pathway, despite the fact that it does not bind to ERE and, consequently, is nonfunctional in the ERE-dependent signaling pathway.
Regulation of endogenous gene expression by E 2 -ERbs
The experimental reporter systems we used here contain minimal promoter sequences responsive to E 2 -ER signaling. While transient transfection into mammalian cells has been a valuable tool for the understanding of action mechanisms of transfactors, nucleosome deposition onto the non-replicating reporter vector displays an incompletely organized nucleosome array in contrast to the replicative cellular chromatin (Archer et al. 1992 , Lee & Archer 1994 , Pennie et al. 1995 . This results in a more accessible chromatin of the transfected DNA that affects basal and transfactor-regulated transcription compared with the responses observed with cellular chromatin (Archer et al. 1992 , Lee & Archer 1994 , Pennie et al. 1995 .
Moreover, the temporal regulation of endogenous E 2 target gene expression is the result of integrated effects of transcription factors that bind to cognate responsive elements within the regulatory regions. The combinatorial effects of transfactors and ER ultimately determine the magnitude and/or direction of the endogenous gene expression (Nunez et al. 1989 , Vyhlidal et al. 2000 . Consistent with heterologous expression systems, as we have demonstrated here (Fig. 2) , the presence of an ERE in the TFF1 gene promoter provides the endogenous responsiveness to E 2 -ER signaling (Nunez et al. 1989) . The regulation of the RARA gene expression is, on the other hand, attributed to ER-SP1 interactions in experimental systems (Rishi et al. 1995 , Sun et al. 1998 , Safe 2001 ), as we also showed here (Fig. 2) and previously ). However, a recent genomics approach identified a long-distance regulatory module that contains a functional ERE responsible for the regulation of the RARA gene expression in breast cancer cell models expressing endogenous ER (Laganiere et al. 2005) .
To ensure that ERb EBD can indeed discriminately regulate endogenous gene expression, we used MDA-MB-231 cells as a model within which exogenously expressed ERs were shown to induce gene expressions that affect phenotypic characteristics (Garcia et al. 1992 , Jiang & Jordan 1992 , Zajchowski et al. 1993 , Lazennec & Katzenellenbogen 1999 , Lazennec et al. 2001 , Licznar et al. 2003 , Moggs et al. 2005 . We also used recombinant adenoviruses for an efficient gene delivery (Huang et al. 2005b) .
Recent studies showed that augmented levels of unliganded ERa lead to aberrant gene expression and an altered phenotype through mechanisms that are distinct from those mediated by E 2 (Fowler et al. 2004 (Fowler et al. , 2006 . To circumvent this potential problem, we used various concentrations of the recombinant adenovirus bearing ERb cDNA (Ad5-ERb) to obtain an optimal MOI that leads to a level of receptor synthesis which requires E 2 to regulate gene expression and cellular growth. We found that MDA-MB-231 cells infected with Ad5-ERb at 600 MOI synthesize a concentration of ERb that is strictly dependent upon E 2 for function (data not shown). The recombinant adenovirus expressing ERb EBD cDNA (ERb EBD ) was used at 900 MOI producing comparable levels of receptor to that of ERb (see also Fig. 3B ). We therefore used 900 MOI of the parent recombinant adenovirus (Ad5), 600 MOI of Ad5-ERb, which was brought to 900 MOI by supplementing with 300 MOI of Ad5, and 900 MOI of ERb EBD in subsequent experiments.
The synthesis of functional receptor protein was examined by ICC, WB, E 2 binding, and EMSA assays in a time-dependent manner in infected MDA-MB-231 cells. ICC revealed that receptor proteins became detectable in the nuclei of infected cells as a function of time such that at 48 h post-infection nearly all cells showed staining for ERb and ERb EBD (Fig. 3A) . This was a reflection of the level of ER synthesis as assessed by WB, which showed that ERb and ERb EBD were synthesized comparably in a timedependent manner (Fig. 3B) . The in situ E 2 binding assay further showed that 3 H-E 2 was similarly retained in cells that synthesize ERb and ERb EBD but not the parent recombinant adenovirus (Fig. 3C) (Fig. 3D) .
Based on these observations, we anticipated that ERb EBD would not regulate endogenous gene expression mediated by the ERE-dependent pathway. Our studies using qPCR revealed that ERb only in the presence of E 2 effectively induced the expression of estrogen-responsive genes mediated by ER-ERE interactions, exemplified by the TFF1 and C3 genes, while ERb EBD had no effect on the expression of these genes (Fig. 4A) . We also observed that E 2 -ERb, but not E 2 -ERb EBD , activated the endogenous RARA gene expression. This is consistent with the finding that the regulation of the RARA gene expression is dependent on ER-ERE interactions (Laganiere et al. 2005) , which is clearly in contrast to the response from the reporter system we observed here and reported previously (Rishi et al. 1995 , Sun et al. 1998 , Safe 2001 . On the other hand, both ERs in the presence of E 2 repressed the expression of the MMP1 gene that models an EREindependent signaling-regulated gene.
To further verify the functionality of ERb EBD and to preliminarily identify the genes mediated by the EREindependent pathway, we used a global gene expression profiling approach. MDA-MB-231 cells were infected with recombinant adenoviruses in the absence of E 2 for 48 h. At this time of post-infection, nearly all cells synthesized receptor proteins at levels that were maximal and comparable (Fig. 3) . The cells were then treated with 10 K9 M E 2 for 6 h, which is expected to induce significant changes in the level of transcription of immediate/early estrogen responsive genes (Frasor et al. 2003) .
Expression profiling revealed that the genes regulated by ERb and ERb EBD are involved in a broad range of function including metabolism, signal transduction, proliferation, apoptosis, and motility (Tables 1  and 2 ). As summarized in Fig. 4B , E 2 -ERb significantly altered the expression of 41 genes, whereas E 2 -ERb EBD regulated the expression of 12 genes, 10 of which were also modified by E 2 -ERb. The majority of the identified genes were suppressed by both E 2 -ERb and E 2 -ERb EBD . E 2 -ERb enhanced the expression of 12 responsive genes, whereas E 2 -ERb EBD augmented the expression of three genes.
We further verified the expression of a subset of the identified genes with qPCR. Infected MDA-MB-231 cells were maintained for 48 h in the absence of E 2 (Fig. 4C) . The cells were then treated without or with 10 K9 M E 2 for 6, 12, and 24 h. Total RNA was subjected to qPCR. As observed with microarrays, only ERb in the presence of E 2 induced the expression of the cyclin-dependent kinase inhibitor (CDKN1A, WAF1 p21, CIP1) and lysyl oxidase-like 4 (LOX4) genes. The expression of the follistatin (FST) gene was indeed repressed by only E 2 -ERb EBD .
E 2 -ERb and E 2 -ERb EBD activated the cysteine-rich secretory protein LCCL domain containing 2 (CRISPLD2) and thromboxane A2 receptor (TBXA2R) gene expressions. On the other hand, both receptors repressed the expression of the MMP1, (SERPINB2) serpin peptidase inhibitor, clade member 2, hyaluronan synthase 2 (HAS2), and heparin-binding EGF-like growth factor (HBEGF) genes in the presence of E 2 .
Thus, ERb EBD is capable of modulating the expression of endogenous genes in response to E 2 .
Differential effects of E 2 -ERb and E 2 -ERb EBD on cell growth
To examine whether the genomic responses mediated by E 2 -ERb EBD participate in the regulation of cellular growth, we used proliferation assays. Infected MDA-MB-231 cells were grown for various durations of time in the absence or presence of 10 K9 M E 2 . The cells were then subjected to cell counting (Fig. 5A ) and MTT assay (Fig. 5B) . Results revealed that ERb or ERb EBD had no effect on cellular growth in the absence of E 2 (data not shown). On the other hand, E 2 treatment of the infected cells synthesizing ERb, but not ERb EBD , decreased the cell number as a function of time. These findings indicate that the E 2 -ERb EBD signaling has no discernable effect on cell proliferation.
Moreover, despite the comparable synthesis as assessed by WB (Fig. 5C ) and the in situ E 2 binding assay (data not shown), the ERE-binding defective ERb EBD (Fig. 5D ) had no effect on cellular growth in the absence or presence of E 2 in infected U-2 OS cells in contrast to E 2 -ERb, which effectively suppressed the proliferation (Fig. 5E ), as observed with MDA-MB-231 cells.
These results suggest that the ERE-independent pathway does not play a critical role in E 2 -ERb signaling to mediate cellular growth.
Effects of E 2 -ERb and E 2 -ERb EBD on cell cycle
The absence of an effect of E 2 -ERb EBD on cellular growth predicts that the ERE-independent pathway mediated by E 2 -ERb is also insufficient to alter cell cycle distribution.
To address this prediction, MDA-MB-231 cells were infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for various durations of time. The cells were then subjected to FACS. The kinetic analysis of histograms (Supplemental data Fig. 1A see Supplementary data in the online of version of the Journal of Molecular Endocrinology at http://jme.molecular.endocrinology-journals.org/content/vol40/issue5/), summarized as the percentile of cells in G1 phase (Fig. 6A) , revealed that ERb, only in the presence of E 2 , increased the number of cells in the G1 phase and decreased the cell number accumulated in the S and G2 phases (data not shown). On the other hand, ERb EBD had little effect on cell cycle distribution whether or not the cells were treated with E 2 . Thus, it appears that E 2 signaling conveyed by ERb through the ERE-independent signaling pathway is insufficient to alter cell cycle distribution.
Since the effects of ERb on the ERE-independent signaling are also dependent on the nature of ligand, we wanted to examine whether ER agonists or antagonists differentially affect cellular growth mediated by ERb EBD . The infected MDA-MB-231 cells were treated without or with 10
K9 M E 2 , 10 K8 M DPN, 10 K7 M of 4-OHT or ICI (data not shown) for 48 h. The cells were also co-treated with 10
K9 M E 2 and 10 K7 M of 4-OHT (or ICI, data not shown), or 10 K8 M DPN together with 10 K7 M of 4-OHT (or ICI, data not shown) for 48 h. These concentrations of ligands are optimally effective to alter the transcription in response to ERb (Fig. 2 and data not shown) . The cells were then subjected to FACS (Supplemental data, Fig. 1B http://jme.molecular.endocrinology-journals.org/content/vol40/issue5). The treatment of the infected cells synthesizing ERb with DPN repressed the cell number accumulated in the G1 phase comparable to that observed with the E 2 treatment, while the compound had no effect on the growth of cells infected with Ad5 or Ad5-ERb EBD . Furthermore, the ER antagonist 4-OHT (or ICI, data not shown) alone did not affect cell cycle distribution in cells synthesizing either ERb species, but it effectively blocked the effect of E 2 or DPN on G1 phase mediated solely by ERb. The effects of ligand-ERb on cell cycle distribution were mirrored in cellular growth, which was suppressed only by agonists (Supplemental data, Fig. 1C http://jme.molecular.endocrinology-journals. org/content/vol40/issue5/).
Regulation of apoptosis by E 2 -ERbs
Since cellular growth encompasses cell proliferation and death, the inability of E 2 -ERb EBD to affect cell growth suggests that the ERE-independent pathway participates minimally in inducing apoptosis, which is a complex, multiple-step event that culminates in cell death (Korsmeyer 1999) . To address this issue, MDA-MB-231 cells were infected in the absence or presence of 10 K9 M E 2 for different lengths of time. The cells were then subjected to caspase 3/7, annexin V, and Ion binding X LI and others . Dissection of nuclear E 2 -ERb signaling TUNEL assays, which assess early-, mid-, and late-stages of apoptosis respectively. We found that ERb EBD had no effect on the activity of caspase 3/7 whether or not the cells were treated with E 2 , while ERb in the presence of E 2 increased the enzyme activities compared with cells infected with Ad5 (Fig. 6B) .
Similar results were obtained with annexin V staining of infected cells (Fig. 6C and Supplemental data, Fig. 2A , see Supplementary data in the online of version of the Journal of Molecular Endocrinology at http:// jme.molecular.endocrinology-journals.org/content/ vol40/issue5/). The number of apoptotic cells in a population of cells infected with a recombinant adenovirus bearing a receptor cDNA was compared with the number of apoptotic cells infected with the parent adenovirus in the absence of E 2 as a function time. We observed that the unliganded or E 2 -bound ERb EBD had no effect on the cell population stained with annexin V, while ERb in response to E 2 increased the number of stained cells.
We corroborated our results with a TUNEL assay by incorporating FITC-conjugated nucleotides into the fragmented genomic DNA (Gorczyca et al. 1998) . Infected MDA-MB-231 cells were incubated without or with 10 K9 M E 2 for various durations of time. The cells were then subjected to the TUNEL assay. Results, depicted as the number of cells stained with TUNEL (Supplemental data, Fig. 2B http://jme.molecular.endocrinology-journals.org/content/vol40/issue5/) and summarized as a function of time (Fig. 6D) , showed that E 2 -ERb induced the fragmentation of genomic DNA of the infected cells. In contrast, ERb EBD had no discernable effect.
Collectively, these results indicate that ERb, but not ERb EBD , induced apoptosis in infected cells treated with E 2 . These results suggest that the ERE-dependent pathway is the critical E 2 -ERb signaling pathway for the induction of apoptosis.
Differential effects of ERb and ERb EBD on cell migration and invasion
Studies showed that ER-positive breast cancer cell models and ER-negative cell lines expressing ectopically introduced ER cDNA are less motile and invasive than the parent cells (Garcia et al. 1997 , Lazennec et al. 2001 .
To examine whether the ERE-independent pathway participates in the anti-motogenic effect of E 2 -ERb signaling, we used wound-healing and invasion assays. MDA-MB-231 cells infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 were grown for 48 h to allow the cells to reach near confluence. A wound was then created and the rate of wound closure was assessed. The results showed that while ERb EBD had little effect on wound closure in the absence or presence of E 2 , ERb without E 2 delayed the wound healing, which was further delayed by the presence of E 2 ( Fig. 6E and Supplemental data, Fig. 2C http://jme.molecular.endocrinology-journals. org/content/vol40/issue5/).
We also utilized an invasion assay that assesses the capacity of cells to migrate through a reconstituted basement membrane to independently verify our findings. MDA-MB-231 cells were infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for 48 h. The cells were then collected, and an equal number of cells were seeded on the reconstituted basement membrane of invasion chambers in the absence or presence of E 2 . After 24 h incubation, cells on the bottom of the chamber membrane were stained and imaged (Supplemental data, Fig. 2D http://jme.molecular.endocrinology-journals.org/content/vol40/issue5/). A quantitative analysis of images revealed that ERb only in response to E 2 , but not E 2 -ERb EBD , reduced invasive cell number (Fig. 6F) . These results collectively suggest that the EREindependent pathway mediated by E 2 -ERb signaling plays a minimal role in cellular motility.
Discussion
The integrated effects of the ERE-dependent and EREindependent nuclear E 2 -ER signaling are critical for the homeodynamic regulation of estrogen-responsive tissue functions. However, the relative importance of each pathway in physiology and pathophysiology of E 2 signaling is unclear. Using an ERE-binding mutant of ERb (ERb EBD ), which acts primarily through the EREindependent pathway, we show here that genomic responses to E 2 -ERb EBD are not sufficient to alter phenotypic characteristics of model cells.
The elements of the nuclear action of ERs involve a multi-step regulation in which ERs are converted from an inactive form to a transcriptionally active state mediated by a conformational change upon E 2 binding (Parker 1998) . The interaction of E 2 -ER with an ERE constitutes the initial step in the ERE-dependent signaling in which the gene expression is cyclically regulated (Metivier et al. 2003) . In the ERE-independent pathway, E 2 -ER functionally interacts with transcription factors bound to their cognate regulatory K9 M E 2 as a function of time as indicated were subjected to a caspase 3/7 assay. The fluorescence was measured using a fluorometer. Results are the meanGS.E.M. of three independent experiments. (C and D) To examine the effects of ERs on cell death, infected MDA-MB-231 cells at indicated times were subjected to (C) an annexin V assay using FACS or (D) a TUNEL assay. Results, which are the meanGS.E.M. of three independent experiments, are summarized as the number of cells bound to annexin V or as the number of cells that incorporated FITC-conjugated dUTP into the fragmented DNA (TUNEL). (E) To assess the role of the EREindependent signaling pathway in cellular motility, infected MDA-MB-231 cells were incubated in the absence or presence of 10 K9 M E 2 for 48 h to allow cells to reach near 100% confluence. A wound was then created and images were captured at 0 h and at every 24 h thereafter. Results, which are the meanG S.E.M. of three independent experiments performed in duplicate, are summarized as the wound closure at 96 h relative to 0 h. (F) To examine the effects of ERs on cellular invasiveness, MDA-MB-231 cells were infected with recombinant adenoviruses in the absence or presence of 10 K9 M E 2 for 48 h. The cells were collected and counted. The same number of cells from each experimental group was then seeded on the upper section of the invasion chamber. After 24 h incubation, those cells with invasive capabilities on the bottom of chamber membrane were counted. Results, which represent the meanGS.E.M. of three independent experiments performed in duplicate, are percent change compared with cells infected with the parent adenovirus in the absence of E 2 , which is set to 100%. *Indicates a significant effect compared with the parent adenovirus (Ad5).
elements on DNA to modulate gene expression (Kushner et al. 2000 , Safe 2001 ). This interaction involves the stabilization of transfactor binding to DNA and/or recruitment of co-regulators to the complex (Kushner et al. 2000 , Safe 2001 . Estrogen regulation of the MMP1 and the insulin-like growth factor-1 (IGF1) genes is, for example, characterized by a functional interaction between the members of the AP1 family proteins and ER (Umayahara et al. 1994 , Kushner et al. 2000 . The modulation of the FOS (cellular oncogene fos) and the progesterone receptor (PGR) gene expressions, on the other hand, are dependent on an the interaction between ER and SP1 (Duan et al. 1998 , Schultz et al. 2003 . Similarly, ER interactions with the signal transducers and activators of transcription (STATs) family proteins provides a mechanism for the estrogen responsiveness of the b-casein (CSN2) gene (Bjornstrom et al. 2001) .
In the ERE-independent signaling, ER establishes interactions with transfactors through regions that also encompass the DBD, while the integrated effects of the amino and carboxyl termini are responsible for the gene expression (Kushner et al. 2000 , Safe 2001 , Bjornstrom & Sjoberg 2002 , Cheung et al. 2005 . Studies also demonstrated that the prevention of ER-ERE interactions by changing critical residues in the DBD of the mouse ERa and the human ERb prevent the transcription from the ERE-dependent pathway, while conserving the regulatory capacity of the receptors in simulated ERE-independent pathways (Jakacka et al. 2001 , Bjornstrom & Sjoberg 2004 . Consistent with these findings, we also show here that ERb EBD , which had no effect on gene expression from the ERE-dependent pathway, mimics the effect of ERb on transcriptional responses from simulated EREindependent signaling pathways in a ligand, promoter, and cell context-dependent manner. Although the underlying mechanisms are unclear, distinct conformational changes induced by a specific ligand (Nettles et al. 2007) could alter the extent of interaction with a transfactor specific to each gene, thereby altering the transcription output. Additionally, cellular differences in the concentration of transfactors and/or co-regulatory proteins (McKenna et al. 1999 ) could contribute to differential effects of ligand-ERs on responses from promoter constructs.
Extending these findings, our microarray and qPCR studies further indicate that ERb EBD in the presence of E 2 regulates the expression of a number of genes, the majority of which (10 out of 12) are similarly modulated by E 2 -ERb in infected MDA-MB-231 cells (Tables 1  and 2 ). Although the nature of the regulatory elements critical for the E 2 responsiveness of the identified genes are unknown and presently being investigated, these genes are also targets for various cytokines and growth factors that utilize transfactors involved in cross-talk with ERs. Growth factor-mediated expression of the MMP1 and MMP3 genes, for example, involves the AP1 proteins (Buttice et al. 1996 , Aho et al. 1997 . Similarly, while the basal expression of the HAS2 gene is primarily controlled by the SP family of proteins (Monslow et al. 2006) , the responsiveness of the gene to endocrine and paracrine signaling is mediated by STAT and the NFkB transcription factors (Pasonen-Seppanen et al. 2003 , Saavalainen et al. 2005 . The protein products of these E 2 -ERb EBD -responsive genes play critical roles in cell growth, death, and migration. Matrix metallopeptidases (MMPs), for example, are a large family of endopeptidases responsible for tissue remodeling and degradation of the extracellular matrix (ECM) that includes collagens, elastins, gelatin, laminin, and matrix glycoproteins (Duffy et al. 2000) . MMP1 is involved in the degradation of collagen, while MMP3 participates in the degradation of many ECM substrates including glycoproteins, laminin, fibronectin, and collagen (Duffy et al. 2000) . Increased MMP1 and MMP3 gene expressions are associated with advanced stages of breast cancer and are involved in the development of metastasis (Duffy et al. 2000) . Similarly, aberrant synthesis of hyaluronan (HA), the major glycosaminoglycan found in the ECM, is implicated in a diverse range of ECM-mediated processes including cellular proliferation, adhesion, and migration (Gotte & Yip 2006) . HA is synthesized by the hyaluronan synthase family of transmembrane glycosyltransferases that are encoded by the corresponding HAS1, -2, -3a, and -3b genes (Gotte & Yip 2006) . Preferential and high expression of the HAS2 gene appears to be critical for invasiveness of breast cancer cells, including MDA-MB-231 cells (Gotte & Yip 2006) . Studies also indicate that an aberrant expression of the SERPINB2 (Andreasen et al. 1997) , HBEGF , DKK1 (Forget et al. 2007) , GPRC5A (Nagahata et al. 2005) , and TBXA2R (Watkins et al. 2005 ) genes alters the proliferation and motility of breast cancer cells.
Considering the ability of ERb EBD to alter gene expression, the absence of an effect of ERb EBD on the phenotypic characteristics of model cells is surprising. Studies indicate that the suppression of HAS2 (Udabage et al. 2005 , Li et al. 2007 or MMP1 (Wyatt et al. 2005) synthesis by a silencing RNA approach decreases the growth and invasiveness of MDA-MB-231 cells. One explanation is that the extent of transcriptional alterations mediated by E 2 -ERb EBD and subsequent changes in RNA levels are not sufficient to modify the corresponding protein concentrations in cells, in contrast to silencing RNA approaches. This is unlikely since the magnitude of E 2 -ERb-mediated transcriptional responses was comparable to those modulated by E 2 -ERb EBD (Fig. 3 and Tables 1 and 2), while only E 2 -ERb induced alterations in cellular phenotypes. An alternative explanation is that the integrated regulation of genes involved in a signaling cascade through both ERE-dependent and ERE-independent pathways is crucial for the manifestation of phenotypic alterations in response to E 2 -ER signaling. The interaction of CD44 with HA, for example, induces signaling events that promote anchorage-independent cell growth and migration, thereby increasing metastatic spread (Gotte & Yip 2006) . Importantly, posttranscriptionally mediated repression of HAS2 leads to a concomitant decrease in its cell surface receptor CD44 transcript (Udabage et al. 2005) . A similar mechanism is also suggested for the members of MMP proteins (Wyatt et al. 2005) . Thus, the concomitant regulation of the HAS2 and the CD44 gene expression, or genes involved in the MMP signaling cascade, by E 2 -ERb, could be the underlying reason for the efficacy of the receptor to induce phenotypic alterations, in contrast to E 2 -ERb EBD which decreased only the HAS2 gene expression without an effect on cellular phenotype.
Transcript profiling of infected MDA-MB-231 cells synthesizing an ERE-binding defective mouse ERa indicated that E 2 alters the expression of a number of genes involved in various cellular functions (Glidewell-Kenney et al. 2005) . However, out of the 29 identified genes, the expression of only the HAS2 and SERPINB2 genes coincides with the altered gene expression reported here. Since transcriptional responses from ERE-independent signaling pathways in experimental systems are also dependent upon ER-subtype, a discordant gene regulation could be critical for differences in subtype-mediated cellular responses.
Augmented synthesis of ERa, as observed in atypical hyperplasia and in situ carcinoma of breast, causes an E 2 -independent, tamoxifen-insensitive proliferation through aberrant gene expressions (Fowler et al. 2004 (Fowler et al. , 2006 . Our studies presented here were designed to assess the role of the ERE-independent signaling pathway mediated by ERb to induce cellular responses at concentrations that strictly depend upon E 2 for function. The circumvention of E 2 -dependency by increased ERb levels could contribute to the characteristics of target tissue malignancies through a selective expansion, or altered expression, of target genes mediated by the ERE-independent signaling pathway.
In summary, our results show that genomic responses mediated by the ERE-binding defective ERb mutant in response to E 2 are insufficient to alter the phenotypic characteristics of model cell lines. These results imply that the ERE-dependent pathway is necessary for E 2 -ERb to regulate growth of the responsive cells. Studies that aim to target specifically ERE-bearing genes through the use of designer transcription factors are underway to address this issue.
